Brain

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

HOUSTON, TX, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased…

4 months ago

EndoUVTech Announces Strategic Partnership with CeramOptec to Advance UV Laser Stroke Therapy Toward FDA Submission

OAKLAND PARK, FL / ACCESS Newswire / August 24, 2025 / EndoUVTech, a medical device innovator pioneering UV laser technology…

4 months ago

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Delay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc.…

4 months ago

Restart Life Sciences Provides Corporate Update on Strategy and Growth Initiatives

Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)…

4 months ago

Prostadine Drops Reviews (Consumer Reports 2025) Is It Safe for Men? Shocking Truth About Results & Complaints

MIAMI, FL / ACCESS Newswire / August 21, 2025 / Constantly having the urge to pee or having trouble urinating…

4 months ago

Audifort Drops Reviews: Does This Herbal Formula Work for Tinnitus Relief? Complete Buyer Guide 2025

TALLMADGE. OH / ACCESS Newswire / August 21, 2025 / Audifort is a hearing health supplement carefully formulated to support…

4 months ago

Apollo Biowellness, Inc., Launches New Product Brand

radeditorformatted_6North Bergen, New Jersey--(Newsfile Corp. - August 21, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), is pleased…

4 months ago

Nalu Advances Wearable Neurostimulation with New, 39% Smaller Therapy Disc

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc., announced the release of a next-generation Therapy Disc—a significantly smaller, lighter and more comfortable version…

4 months ago

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY /…

4 months ago

Neurocare Group Receives FDA Clearance for Treatment of OCD With Its Transcranial Magnetic Stimulation (TMS) Devices

neurocare's Apollo TMS Therapy systems are now FDA-cleared for the treatment of Obsessive Compulsive Disorder, offering a new non-drug treatment…

4 months ago